Introduction
A new signal amplification method, termed catalyzed reporter deposition (CARD), was introduced by Bobrow et al. (1989) to enhance the efficiency (Petrusz et al., 1980) of biotin-avidin detection systems in solid-phase assays. The signal amplification is achieved by the deposition of biotin-conjugated tyramine, facilitated by hotseradish peroxidase enzyme (W). The biotin amplification method was later utilized for immunohistochemistry by Adams (1992), either to detect weak signals or to reduce the incubation times, using the diaminobenzidine (DAB) detection system. Berghorn et al.
(1994) applied the biotin amplification method for immunofluorescent signal detection in histochemistry, enhancing the detection of cFos immunoreactivity.
In this study we demonstrate the utility of the CARD amplification method for both fluorescent and peroxidase detection systems using several monoclonal and polyclonal antibodies in different rat tissues. We also report here the applicability of the signal amplification method in double immunostaining, using primary antibody pairs raised in the same host species.
Materials and Methods

Chemicals and Bagen
The following standard buffers and chemicals were used: 1 M Tris-HC1 pH 8.0 (Quality Biological, Gaithersburg. MD; catalog #351-007-loo), 10 x PBS, pH 7.4 (BioWhittaker. Walkersville, MD; #16-006VN), sodium chloride UT Baker, Phillipsburg. NJ; #57-50-1). paraformaldehyde (Polysciences, Warrington, PA; #0380), bovine serum albumin (ICN Biomedicals, Aurora, O H #160069), Triton X-100 (Research Products International, Elk Grove Village, IL; #111036), sucrose UT Baker; #57-50-1) 3.3-diaminobenzidine tetrahydrochloride (DAB) (Sigma; St. Louis, MO).
From these reagents, 1 x PBS (pH 7.4), 1 x Tris-buffered saline (TBS: 0.1 M Tris-HCI, 0.15 M NaCl in distilled water, pH 8.0). 0.1 M Tris-HC1
(pH 8.0). a bovine serum albumin containing diluent (BSA diluent: 1% bovine Serum albumin, 0.6 v/v% Triton X-100 in 1 x PBS, pH 7.4). the paraformaldehyde fuative (4% paraformaldehyde in 1 x PBS, pH 7.4), and the DAB solution (40 mg% DAB, 0.016% Hz02 in 0.1 M %is-HC1, pH 8.0. prepared fresh and used for 7-10 min) were prepared. Both 1 x PBS (pH 7.4) and 1 x TBS (pH 8.0) were used in washes and transfers betwcen different steps of the immunostaining three tima for 5 min. Unless otherwise mentioned, all the procedures were executed at room temperature (RT, .u20°C ).
Animals and Tissue Handling
Adult male Sprague-Dawley rats (Taconic Farms, Germantown, Ny; 250-300 g) were sacrificed by decapitation under anesthesia (80 mglkg pentobarbital sodium IP) (Anpro Pharmaceutical, Arcadia, CA; #NDC 51940-022). The stomach, pancreas, and brain were rapidly removed and immediately frozen on dry ice. Alternatively, some animals were paraformaldehyde-perfused through the ascending aorta under pentobarbital anesthesia, as follows. The chest of the anesthetized animal was opened and the ascending aorta cannulated through the left ventricle. After opening of the left atrium, the vasculature was washed with 100 ml of 0.9% NaCl (37'C) for 5 min using a perfusion pump (Ismatec MV-CA; Zurich, Switzerland). The animals were then perfused with 500 ml4% paraformaldehyde fixative for 20 min. The organs were removed and postfixed in the same fixative for 30 min. Then the tissues were cryoprotected in 5% (2 hr), 10% (4 hr). and 20% (over-'night, 4'C) sucrose in 1 x PBS (pH 7.4) solution and frozen in 2-meth-$butane (Aldrich, Milwaukee, WI; #M3,263-1). National Research Council guidelines were followed in all the animal procedures. Frozen tissues mounted in Tissue-Tek OCT Compound (Miles, Elkhart, IN, #4583), were cut in 6-or 12-~m-thick sections in a cryostat (Frigocut-E 2800; Reichert-Jung, Heidelberg, Germany). The sections were thawmounted and air-dried at 37'C onto silanized slides, frozen, and stored at -8o'C until used.
Immunohistochemical Methods
The frozen sections were fixed in 4% paraformaldehyde fixative for 10 min, followed by washes in PBS. To decrease nonspecific staining, the fixed sections were incubated in BSA diluent for 30 min and washed in PBS. The schematic protocols of the applied immunohistochemical procedures are summarized in liable 1. We refer to the different immunostaining paths by the letters in italics according to this table.
The primary antibodies used for the immunostainings are listed in Table 2. The undiluted supernatants or ascites fluids (for mouse monoclonal antibodies) and the undiluted sera (for rabbit polyclonal antibodies) were used as stock solutions (dilution 1:l). We diluted the primary antibody for the conventional and amplified stainings from the same stock in each case. The dilution with the optimal signallbackground ratio was carefully titered for each antibody.
After the immunostainings described below, the sections were washed in distilled water, air-dried, and coverslipped using the C y t d 60 mounting medium (Stephens Scientific, Riverdale, NJ; #8310-4). Immunofluorescent labeling was viewed with a fluorescent microscope (Litz Dialux 20, Oberkochen, Germany; U307-143.004) using green, red, and ultraviolet filters.
Conventional Immunofluorescent Staining (Path a). Primary antibodies (Table 2) diluted in the BSA diluent were applied to the sections for 1 hr, followed by washes in PBS. Subsequently, the sections were incubated in affinity-purified indicarbgranine (Cy3, viewed in red field, 1:1,000 in BSA diluent) or fluorescein isothiocyanate (FITC, viewed in green field, 1:lOO in BSA diluent) fluorochrome-conjugated secondary antibodies [F(ab)z fragments; Table 3 ) to either mouse or rabbit IgGs, depending on the primary antibody, for 1 hr, followed by washes in PBS. Negative controls included incubations in nonimmune mouse IgG or normal rabbit serum instead of the primary antibody and leaving out the primary and/or the secondary antibodies.
Conventional Immunoperoxidase Staining (Paths b,c). In this procedure, before the incubation with the pcimary antibody, the endogenous peroxidase activity was blocked by a 30-min incubation in 3% H202 in methanol. The sections were washed in PBS, incubated in the primary antibody (Table 2) for 1 hr, and washed again in PBS. After that, either an HRP-conjugated (Table 3 ) ot a biotin-conjugated (Table 3 ) secondary antibody was used, both at a dilution of 1:500 in BSA diluent for 1 hr, followed by washes in PBS. After the biotin-conjugated secondary antibody, we used an avidin-biotin-peroxidase complex (ABC reagent; Vectastain ABC Elite kit, Vector Laboratories, Burlingame, CA) at dilutions of 1:250 'A" and 1:250 "B' in BSA diluent, prepared at least 30 min before use for 1 hr.
The ABC reagent can be equivalently replaced by streptavidin-HRP (Table 3) at a dilution of 1:2000 in BSA diluent for l hr. After washes in PBS, the sections were transferred to TBS and the peroxidase activity was demonstrated using the DAB substrate, followed by washes in TBS. Negative controls were as above.
Signal Amplification Methods (Paths d-o) . The principle of the signal amplification is the enzymatically facilitated deposition of tyramine that is conjugated to either biotin or a fluorochrome (Hunyady et al.. in press), catalyzed by an immunologically introduced HRP enzyme. All ofthe procedures, started as conventional immunostainings, can be amplified by different methods. Amplifications finished by any fluorochrome conjugate are called immunofluorescent amplifications, and amplifications finished by DAB are referred to immunoperoxidase amplifications.
For the signal amplification, the Renaissance TSA Amplification kit (DuPont NEN, Wilmington, DE; #NEL700) was used, containing HRPconjugated anti-FIX tertiary antibody (anti-FIX-HRP, used at a dilution of 1:lOOO in BSA diluent), 2 x amplification diluent, FIX-tyramide (tyr-FIX; 1:2000 in 1 x amplification diluent), rhodamine-tyramide (tyr-RHOD; 1:5000 in 1 x amplification diluent), coumarin-tyramide (tyr-AMCA; 1:2000 in 1 x amplification diluent), biotinyl-tyramide (tyramide (tyr-BIOT; 1:lOO in 1 x amplification diluent), streptavidin- Table 3 Table 2) were prepared in BSA diluent. The incubation with the primary antibody (1 hr) was followed by washes in PBS and by incubation with HRF' (Paths d-g)-, biotin (Paths h-k) ; or FITC (Paths Go)-conjugated anti IgG secondary antibodies, as in the conventional immunostainings. followed by washes in PBS. For a biotin-conjugated secondary antibody (Paths &&), the ABC reagent was subsequently used, as in the conventional immunoperoxidase stainings. The ABC reagent can be equivalently replaced by str-HRP. For an FIX-conjugated secondary antibody (Paths Go), anti-FIE-HRP tertiary antibody (Table 2) From the steps in which either tyr-FITC or str-FITC is used, reamplification cycles can be started repeating the anti-FIK-HRP antibody and the subsequent steps. Similarly, when str-HRP is used after tyr-BIOT, a reamplifcation cycle is possible using tyr-BIOTsubstrate again (instead ofDAB or fluorochrome-tyramides).
. Fluorochrome-, horseradish peroxidase (HRP)-, and biotin-conjugated secondary antibodieJ, biotinyl-tyramide, fluorochrome-tyramide, and fluorochromeor HRP-streptauidin conjugates
To evaluate the dficiency ofthe fluorescent amplification method, we applied the conventional Cy3-or FIX-conjugated secondary antibodies either directly after the incubation in the diluted primary antibodies or after the successful signal amplification. perrmidase amplifications were similarly compared to conventional peroxidase stainings. To confirm the specificity of the amplification method, we performed conventional immunostaining using the regular dilutions of the primary antibodies, either in an adjacent 6-pm-thick section or in the same section after the amplification procedure. Both the efficiency and the specificity of the fluorescent amplifications were directly evaluated when the conventional fluorescent staining (Path a). finished by FIX, was amplified in the same section using a fluorochrome conjugate different from FIK as the final step (Paths Gn). Double Immunost?ining Method with Two Antibodies from the Same Host Species. Double immunostainings consisted of an amplified fluorescent staining (preferably Path I) with the diluted first primary antibody and a subsequent conventional fluorescent staining (Path a) with the second primary antibody, raised in the same host species. The fluorochrome (it., FIX) used in the amplification for the first antigen was different from that used in the conventional staining for the second antigen (i.e., Cy3). W e demonstrate here a double immunostaining using a pair of rabbit antibodies to glucagon (GLUC amplified at a dilution of 1:5000 on Path I) and neurofilament M (NF; conventionally stained at a dilution of 1:2OOO on Path a) in a section of nonperfused rat pancreas. In another example, a pair of monoclonal antibodies, to tyrosine hydroxylase enzyme (TH, amplified at a dilution of 1:7500 on Path /) and oxytocin (OT; conventionally stained at a dilution of 1:500 on Path a), were used in a section of nonperfused rat hypothalamus. In both cases, tyr-FITC was used in a simple fluorescent amplification (Path /) for the first antigen and Cy3-conjugated secondary antibody was used in the conventional immunostaining (Path a) for the second antigen. We used the dilution of the first primary antibody, which was consistently not recognized by a conventional Cy3Jabeled secondary antibody but was still clearly detectable by a simple fluorescent amplification method. In addition to the controls described for the amplified immunofluorescent methods, we also used consecutive sections immunostained conventionally for either antigen separately. Furthermore, we selected antigen pairs for these double stainings that are known to be present in different cells. Therefore, we could have easily recognized any crossreaction between the first primary antibody and the second secondary antibody.
Results
Application of fluorochrome-tyramide conjugates in one step, directly after the introduction of the HRP enzyme, successfully increased the signal intensity. From the three options of HRP enzyme introduction, the efficiency gradually increased as follows: secondary antibody-HRP (Paths d-g) <secondary antibody-biotin followed by ABC reagent or str-HRP (Paths h-R) <secondary antibody-FIX followed by anti-FIE-HRP (Paths 1-0) .
Using the simple (Path L) or altemative (Path m) fluorescent amplification method, we were able to detect all antigens in an at least 10-fold lower concentration of primary antibodies than was used in the conventional immunostainings. The immunoperoxidase detection limit increased in the same range. As an extremity, we could clearly detect the HK antigen diluting the primary antibody either 100-fold (1:100,000) of the conventionally used (1:lOOO) by an altemative fluorescent amplification (Path m), or 150-fold (1:150,000) by a forced fluorescent amplification (Path n) ( Figure  1) . The efficiency of peroxidase detection of the proton pump was increased 50-fold ( Figure 2) .
The antibody to PP labeled clearly in perfused pancreas tissue at a dilution of 1:10. However, the signal was very weak in the nonperfused tissue. By a simple fluorescent amplification (Path I), the signal was successfully amplified in the nonperfused tissue even when the primary antibody was used at a fivefold higher dilution (1:50) than conventionally (1:lO) ( Figure 3) .
Reamplifications (other than the forced immunofluorescent amplification) were of moderate value in our experience, particularly when used after tyr-FIE. Either a weak additional increase of the signal or an unacceptably high background staining was seen.
Double immunostainings using primary antibodies raised in the same host species are shown in Figures 4 and 5 . At a 20-fold dilution of the first primary antibody (raised in rabbit to GLUC, 1:5000) of that used in the conventional immunostainings (1:250), a clear signal was seen after a simple fluorescent amplification by tyr-FIX (Path I) in nonperfused rat pancreas. At this dilution of the antibody there was no detectable signal using the conventional Cy3-conjugated anti-rabbit IgG secondary antibody, applied either directly after the incubation with the diluted primary antibody or after the successful signal amplification procedure. When we subsequently immunostained the NF in the same section by the conventional fluorescent method (Path u) using a second primary antibody (also raised in rabbit) and Cy3-conjugated anti-rabbit IgG second secondary antibody, no crossreaction of the first primary antibody and the second secondary antibody was observed in the red fluorescent field (Figure 4) .
Similarly, we were successful using two monoclonal antibodies in the same section of the rat hypothalamus. The first primary antibody, to TH. was diluted to fifteen times (1:7500) the conventional dilution (1500) and was clearly amplified by the simple fluorescent amplification method (Path I). The second primary antibody, to OT, was conventionally immunostained (Path u) using Cy3-conjugated second secondary antibody in the same section.
Only the OT cells were seen in the red fluorescent field, indicating that the first primary antibody (TH) was not detectable with the Cy3-conjugated second secondary antibody (Figure 5 ) .
Discussion
We applied the CARD method described by Bobrow et al. (1989) to amplify immunohistochemical signals of several antibodies in different rat tissues. We demonstrated that the efficiency of both immunofluorescent and immunoperoxidase stainings can be increased 10-to 100-fold compared to conventional immunostaining.
We used commercially available or well-characterized antibodies in this study. The specificity of these antibodies and the distribution ofthe antigens in the particular tissues are known. Our results demonstrate convincingly that the specificity ofthe immunostaining will not be affected by the amplification method. In fact, the efficiency significantly increased, whereas the specificity was maintained and the background did not increase (except after reamplification cycles). On the basis of the signallbackground ratio, introduction of the HRP enzyme as an anti-FIX-HRP conjugate yielded the most efficient amplification result.
The multiplied efficiency achieved by the amplification method might be of value for weak antigens or when the tissue must be fixed with a suboptimal fixation procedure. Our antibody to pancreatic polypeptide labeled clearly in perfused pancreas tissue sections but failed in nonperfused tissues when used conventionally (Reddy et al., 1985) . The weak staining in nonperfused tissue sections was effectively amplified by the CARD method, even with a fivefold diluted primary antibody. This advantage of the amplification method might be beneficial in human diagnostics and pathology, where mostly frozen samples can be studied. The amplification method may also be useful on co-stainings when the antigens to be detected require different special fixations.
A new aspect and field of the amplification method is its application for double immunostainings with primary antibodies from the same host species. Double immunostainings are easy and convenient when antibodies from different host species are available. Unfortunately, in many cascs the availability of the antibodies is limited to only one per antigen. Therefore, there is no possibility to use antibodies from different host species for double immunestaining. We report here a successful new strategy to solve this technical problem. The first primary antibody, used at a very low concentration, can not be detected by conventional secondary antibodies but is still clearly detectable by a fluorescent amplification method. The second primary antibody, raised in the same host species, can be subsequently stained by a conventional fluorescent method using a different fluorochrome. We demonstrated here the efficiency and the reliability of this method, using antibody pairs that are known to label easily distinguishable cell types. By careful titration of the first primary antibody, the interaction between the first primary and the second secondary antibody remains under the detection limit. According to our experience, a successful double immunostaining can be presumed when the first antigen can be clearly detected at an at least 10-fold lower concentration of primary antibody than the conventional dilution. Our preferred amplification path (simple fluorescent amplification, Path 4 consistently allowed at least a lo-fold dilution of primary antibodies, On the other hand. this is the shortest protocol with a direct opportunity to confirm that the first primary antibody cannot be detected without amplification (after the step of anti-IgG-FIX conjugate). For this particular reason, we recommend this method for the double labeling strategy.
We used fluorochrome conjugated F(ab)z fragment secondary antibodies in the double stainings demonstrated here. The absence of the F(c) fragment helped to avoid aspeclfic secondary antibody binding to F(c) receptor-containing immune cells, particularly in the stomach. However, for the signal amplification and double Iabeling strategy, whole IgGs were used with the same effkiency by the authors. Application of an F(ab)2 fragment as the most specific secondary antibody is not a crucial element of our double staining strategy, in contrast to some other methods using F(ab) fragments for double labeling (Negoescu et al. 1994; Lewis Carl et al., 1993; Franzusoff et al., 1991; Wessel and McClay, 1986 ) (see also the Jackson ImmunoResearch catalog, 1996, pp. 23-24) . The essential &rence between our method and all the other F(ab) double labeling methods is that in our method we cannot detect the first antibody I Figure 5 . Double immunogtaining in the rat hypothalamus using two mouse monocle nal antibodies b tyrosine hydroxylase enzyme (TH, amplified, Path /) and oxytocin (conventionally stained. Path a). Diluting the primary antibody to TH by 15-fold (1:7500) of the conventionally used (1:500) , the signal (anowheads) wasstill clearty detectaMe in the green flwresmnt field (A) using asim plefluo"tamplif" . *.
binding to the first antigen without an amplification step, whereas
